River Vision Development Corporation Report issue

For profit Phase 2
Founded: New York NY United States (2011)
Status: Acquired by Horizon Pharma (2017)

Organization Overview

First Clinical Trial
2013
NCT01868997
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree